RADIOTHERAPY

This study is testing a new combination treatment for people with esophageal cancer that is difficult or impossible to remove with surgery right away. The goal is to see if adding a very low dose of radiation to the intestines to an immunotherapy and chemotherapy regimen can shri…

This study is testing a treatment plan for muscle-invasive bladder cancer that aims to avoid major surgery. It combines chemotherapy, an immunotherapy drug (toripalimab), and radiation therapy to try to eliminate the cancer while preserving the patient's bladder. The main goals a…

This large trial is testing if doctors can safely shrink the area they target with radiation for patients with advanced nasopharyngeal cancer (a type of head and neck cancer). All patients get chemotherapy first, then are randomly assigned to have radiation aimed at either their …

This study is testing whether adding a new drug called olaparib to the standard radiation and chemotherapy treatment can better control aggressive brain tumors that cannot be fully removed by surgery. It aims to find the safest dose and see if this combination helps patients live…

This study is testing if adding an immunotherapy drug (camrelizumab) to standard radiation helps shrink tumors before surgery for esophageal cancer. It will involve 25 patients with operable esophageal squamous cell carcinoma. The main goals are to see if this combination is safe…

This study aims to find better ways to monitor and treat a specific type of cervical cancer (adenocarcinoma) after patients complete initial radiation and chemotherapy. It will follow 60 patients to see if detailed imaging and tissue analysis can help doctors decide the best next…

This early-stage trial is testing whether injecting a nanoparticle called NBTXR3 directly into a tumor, then activating it with radiation, can make immunotherapy work better for people with advanced cancers. The study will enroll about 145 patients with various cancers that have …

This study is testing whether a shorter, 1-week radiation treatment is as effective as the standard 3-week treatment for breast cancer patients who need radiation after surgery. The main goal is to see if the shorter treatment causes less arm swelling (lymphedema) while still con…

This study aims to develop better methods for monitoring how rectal cancer responds to chemotherapy and radiation treatment. Researchers will track 40 patients using repeated MRI scans and blood tests to detect cancer cells during their treatment. The goal is to create a model th…

This study tests whether adding weekly check-ins with specially trained medical technicians helps doctors better identify and track treatment side effects in patients receiving proton therapy for brain tumors. The trial involves 92 adult patients and randomly assigns them to rece…